ArticleMolecular cancer therapeutics2025

Depleting the Action of EZH2 through PI3K-mTOR Inhibition to Overcome Metastasis and Immunotherapy Resistance in Triple-Negative Breast Cancer.

Michelle Melino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.